0002137361-26-000002.txt : 20260828 0002137361-26-000002.hdr.sgml : 20260828 20260828153055 ACCESSION NUMBER: 0002137361-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260828 DATE AS OF CHANGE: 20260828 EFFECTIVENESS DATE: 20260828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monocacy Therapeutics Inc. CENTRAL INDEX KEY: 0002137361 ORGANIZATION NAME: EIN: 412998999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-585336 FILM NUMBER: 261339298 BUSINESS ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 BUSINESS PHONE: 3019790911 MAIL ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 D/A 1 primary_doc.xml X0708 D/A LIVE 0002137361 Monocacy Therapeutics Inc. 4716 MONROVIA BLVD MONROVIA MD MARYLAND 21770 3019790911 DELAWARE None None Corporation true 2025 Suman Vodnala 2835 Crusader Street Alameda CA CALIFORNIA 94501 Executive Officer Shashank Patel 4716 Monrovia Blvd Monrovia MD MARYLAND 21770 Executive Officer Director Biotechnology Decline to Disclose 06b true 0002137361-26-000001 2026-05-05 true true false 10000 Indefinite 114450 Indefinite false 2 0 0 0 false Monocacy Therapeutics Inc. /s/ Shashank Patel Shashank Patel President 2026-08-28